Literature DB >> 22697136

The impact of sexually transmissible infection programs in remote Aboriginal communities in Australia: a systematic review.

Rebecca Guy1, James S Ward, Kirsty S Smith, Jiunn-Yih Su, Rae-Lin Huang, Annie Tangey, Steven Skov, Alice Rumbold, Bronwyn Silver, Basil Donovan, John M Kaldor.   

Abstract

OBJECTIVE: To systematically review evaluations of the impact of sexually transmissible infection (STI) programs delivered by primary health care services in remote Aboriginal communities.
METHODS: PubMed, Google Scholar, InfoNet, Cochrane Controlled Trials Register, Australian New Zealand Clinical Trial Registry, conference proceedings and bulletins were searched to April 2011 using variations of the terms 'Aboriginal', 'programs' and 'STI'. The primary outcome of interest in the review was the change in bacterial STI infection prevalence in the target age group assessed through cross-sectional screening studies over a 5-year period or more. The characteristics of the primary health care service, STI programs and other clinical service outcomes were also described.
RESULTS: Twelve reports described four distinct STI programs in remote communities and their impact on STI prevalence. In the Anangu Pitjantjatjara Yankunytjatjara (APY) lands of northern South Australia, there was a reduction in the age-adjusted chlamydia and gonorrhoea prevalence by 58% and 67%, respectively (1996-2003). In the Tiwi Islands of Northern Territory (NT), chlamydia and gonorrhoea positivity decreased by 94% and 34%, respectively (2002-2005). In the Ngaanyatjarra Lands of Western Australia, crude chlamydia and gonorrhoea prevalence decreased by 36% and 48%, respectively (2001-2005), and in the central Australian region of NT, there was no sustained decline in crude prevalence (2001-2005).
CONCLUSION: In three of the four programs, there was some evidence that clinical best practice and well coordinated sexual health programs can reduce STI prevalence in remote Aboriginal communities.

Entities:  

Mesh:

Year:  2012        PMID: 22697136     DOI: 10.1071/SH11074

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  11 in total

1.  Exploring the Benefits of Molecular Testing for Gonorrhoea Antibiotic Resistance Surveillance in Remote Settings.

Authors:  Ben B Hui; Nathan Ryder; Jiunn-Yih Su; James Ward; Marcus Y Chen; Basil Donovan; Christopher K Fairley; Rebecca J Guy; Monica M Lahra; Mathew G Law; David M Whiley; David G Regan
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240

2.  Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study.

Authors:  L Natoli; R J Guy; M Shephard; D Whiley; S N Tabrizi; J Ward; D G Regan; S G Badman; D A Anderson; J Kaldor; L Maher
Journal:  BMJ Open       Date:  2015-04-28       Impact factor: 2.692

3.  STI in remote communities: improved and enhanced primary health care (STRIVE) study protocol: a cluster randomised controlled trial comparing 'usual practice' STI care to enhanced care in remote primary health care services in Australia.

Authors:  James Ward; Skye McGregor; Rebecca J Guy; Alice R Rumbold; Linda Garton; Bronwyn J Silver; Debbie Taylor-Thomson; Belinda Hengel; Janet Knox; Amalie Dyda; Matthew G Law; Handan Wand; Basil Donovan; Christopher K Fairley; Steven Skov; Donna Ah Chee; John Boffa; David Glance; Robyn McDermott; Lisa Maher; John M Kaldor
Journal:  BMC Infect Dis       Date:  2013-09-09       Impact factor: 3.090

4.  Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice.

Authors:  Lisa Natoli; Lisa Maher; Mark Shephard; Belinda Hengel; Annie Tangey; Steven G Badman; James Ward; Rebecca J Guy
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

5.  "I Do Feel Like a Scientist at Times": A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting.

Authors:  Lisa Natoli; Rebecca J Guy; Mark Shephard; Louise Causer; Steven G Badman; Belinda Hengel; Annie Tangey; James Ward; Tony Coburn; David Anderson; John Kaldor; Lisa Maher
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

Review 6.  Does Indigenous health research have impact? A systematic review of reviews.

Authors:  Irina Kinchin; Janya Mccalman; Roxanne Bainbridge; Komla Tsey; Felecia Watkin Lui
Journal:  Int J Equity Health       Date:  2017-03-21

7.  Population movement can sustain STI prevalence in remote Australian indigenous communities.

Authors:  Ben B Hui; Richard T Gray; David P Wilson; James S Ward; Anthony M A Smith; David J Philip; Matthew G Law; Jane S Hocking; David G Regan
Journal:  BMC Infect Dis       Date:  2013-04-25       Impact factor: 3.090

8.  Hospitalisations for pelvic inflammatory disease temporally related to a diagnosis of Chlamydia or gonorrhoea: a retrospective cohort study.

Authors:  Joanne Reekie; Basil Donovan; Rebecca Guy; Jane S Hocking; Louisa Jorm; John M Kaldor; Donna B Mak; David Preen; Sallie Pearson; Christine L Roberts; Louise Stewart; Handan Wand; James Ward; Bette Liu
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

9.  A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the "TTANGO" trial protocol.

Authors:  Rebecca J Guy; Lisa Natoli; James Ward; Louise Causer; Belinda Hengel; David Whiley; Sepehr N Tabrizi; Basil Donovan; Christopher K Fairley; Steven B Badman; Annie Tangey; Handan Wand; Mark Shephard; David G Regan; David Wilson; David Anderson; John M Kaldor
Journal:  BMC Infect Dis       Date:  2013-10-18       Impact factor: 3.090

10.  Perspectives of primary health care staff on the implementation of a sexual health quality improvement program: a qualitative study in remote aboriginal communities in Australia.

Authors:  Belinda Hengel; Stephen Bell; Linda Garton; James Ward; Alice Rumbold; Debbie Taylor-Thomson; Bronwyn Silver; Skye McGregor; Amalie Dyda; Janet Knox; Rebecca Guy; Lisa Maher; John Martin Kaldor
Journal:  BMC Health Serv Res       Date:  2018-04-02       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.